NIK-driven IL-23 production by myeloid cells is a key factor in the development of autoimmune inflammation.

Saved in:
Bibliographic Details
Title: NIK-driven IL-23 production by myeloid cells is a key factor in the development of autoimmune inflammation.
Authors: Ramphal NS; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University Mainz , Mainz, Germany., Liu X; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University Mainz , Mainz, Germany., Palagi I; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University Mainz , Mainz, Germany., Jasser R; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University Mainz , Mainz, Germany., Mohebiany AN; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University Mainz , Mainz, Germany., Klein M; Institute for Immunology, University Medical Center of the Johannes Gutenberg, University Mainz , Mainz, Germany., Westermann F; Institute of Experimental Immunology, University of Zurich , Zurich, Switzerland., Krishnarajah S; Institute of Experimental Immunology, University of Zurich , Zurich, Switzerland., Regen T; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University Mainz , Mainz, Germany.; Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University of Mainz, Germany., Bopp T; Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University of Mainz, Germany.; Institute for Immunology, University Medical Center of the Johannes Gutenberg, University Mainz , Mainz, Germany., Becher B; Institute of Experimental Immunology, University of Zurich , Zurich, Switzerland., Waisman A; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University Mainz , Mainz, Germany.; Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University of Mainz, Germany.
Source: The Journal of experimental medicine [J Exp Med] 2026 Apr 06; Vol. 223 (4). Date of Electronic Publication: 2026 Feb 27.
Publication Type: Journal Article
Journal Info: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1540-9538
DOI:10.1084/jem.20242294